|
Category: Investment, Biotech
Biotech Stocks Directory Update for Investors, following Passing of Health Care Bill
POINT ROBERTS, Wash., Delta, B.C - March 22, 2010 - www.BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.com, updates the biotech stocks directory for investors following the biotechnology and life sciences sector, following the passing of the US Health Care Bill.
Biotech Stocks Directory Preview of Publicly traded Biotech Stocks, Medical Stocks, Life Sciences and Pharma Stocks
3SBio Inc. (NasdaqGS:SSRX) 3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.
Aastrom Biosciences, Inc. (NasdaqCM: ASTM) Aastrom is a leader in the development of autologous cell products for the repair or regeneration of human tissue. The Company's proprietary Tissue Repair Cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. Aastrom's TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. The TRC technology platform has positioned Aastrom to advance multiple products into clinical development. Ongoing development activities are focused on applications of the technology to cardiac and vascular regeneration. The Company currently has a cardiovascular regeneration product in Phase II development for the treatment of dilated cardiomyopathy (DCM) (called the IMPACT-DCM trial) and critical limb ischemia (called the RESTORE-CLI trial).
ABAXIS, Inc. (NasdaqGS: ABAX) Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.
ABBOTT LABORATORIES (NYSE: ABT) Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.
ABIOMED INC (NasdaqGM:ABMD) Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart.
Abviva, Inc (OTCPK:ABVV) is a publicly traded biomedical company established to develop and commercialize diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. Abviva intends to build a fully-integrated diagnostic and therapeutic business that is sustained by future revenues from products and services the company develops; to commercialize the Mammastatin Serum Assay through our wholly owned subsidiary laboratory; and, to develop one or more breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institutions world wide.
Acadia Pharmaceuticals Inc. (NasdaqGM: ACAD) ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is focused on developing a portfolio of its four most advanced product candidates, including pimavanserin in Phase III for Parkinson's disease psychosis, a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and ACP-106 in IND-track development. All of the product candidates in ACADIA's pipeline emanate from discoveries made using its proprietary drug discovery platform.
Visit the Biotech stocks Directory: http://www.investorideas.com/Research/Biotech,PharmaStocks.asp
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Biotech public and private companies can submit news releases at: http://www.investorideas.com/News-Upload/
Learn about becoming a Biotech Showcase company: http://www.investorideas.com/Investors/Biotech_Life_Science_Stocks_Awareness.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.
Investorideas.com Membership – Access full Biotech Stocks Directory, water stocks and more...
With markets and investor sentiment changing daily- it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the complete renewable energy stocks directory, water stocks, biotech and defense stocks directory, as well as the Insiders Corner by Michael Brush.
Become an InvestorIdeas.com - Learn more: http://www.investorideas.com/membership/
Investors are also reminded to sign for the free investor newsletter – the next great investor idea! Investors can sign up for the new free newsletter on the pop-up box on the home page of www.investorideas.com or the newsletter sign up page.
InvestorIdeas.com Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp
Our sites do not make recommendations, but offer information portals to investors to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of any information presented. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is compensated by featured companies, news submissions and online advertising.
For more information contact:
Dawn Van Zant 800.665.0411 dvanzant@investorideas.com
Or cvanzant@investorideas.com
Published at the Investor Ideas Newswire
Investors: Sign up for free newsletter, stock and sector news alerts at Investorideas.com - Or publish your own stock picks and share your investing and trading ideas with other investors. Publish your investor ideas today!
Investorideas.com goal for 2010: 'One Million Members Stronger', empowering one million investors to invest in innovation and technology for a better world. Join us today!
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
|
